Skip to main content
Equibles

Woodline Partners LP

Position in EXEL — Exelixis, Inc.

CIK 1784547 San Francisco, CA
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,411,049
+$6,669,667 QoQ
Shares Held
485,408
+7.8% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#72
of 756 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. EXEL ranks #48 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in EXEL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,411,049 485,408
2025-12-31 $19,741,382 450,408
2025-09-30 $21,427,100 518,816
2025-06-30 $31,949,889 724,816
2025-03-31 $30,152,305 816,693
2024-12-31 $33,117,915 994,532
2024-09-30 $25,771,723 993,130
2024-06-30 $22,180,002 987,094
2024-03-31 $23,423,740 987,094
2023-12-31 $23,680,385 987,094
2023-09-30 $21,568,003 987,094
2023-06-30 $4,949,490 259,000
2022-03-31 $13,642,806 601,800
2021-12-31 $11,000,904 601,800
2021-09-30 $12,722,052 601,800
2021-06-30 $10,964,796 601,800
2021-03-31 $13,515,777 598,308
2020-12-31 $5,475,096 272,800
2020-09-30 $32,075,637 1,311,887